TULANE TALK

January 30, 2009

Good Morning:

I am pleased to announce that the Board of Tulane has appointed two new members – Kim Boyle and Michael Friedman.

Kim, a native of New Orleans and graduate of Princeton University and the University of Virginia School of Law, is a partner in the employment law group in the New Orleans office of Phelps Dunbar LLP. Kim practices in the areas of labor and employment, civil rights, constitutional law, commercial litigation and general litigation.

Joining the Board of Tulane is the latest in Kim’s long commitment to New Orleans. She has also served as co-chair for the Committee for a Better New Orleans/Metropolitan Area Committee; is a current member of the local advisory board for the United Negro College Fund; former secretary and current board member of the Greater New Orleans Foundation; a former trustee for the WYES-12 board of directors; and a former board member on the Bureau of Governmental Research. She has also served as chair of the Louisiana Recovery Authority’s Healthcare Committee and previously served on the Bring New Orleans Back Commission as chair of its Health/Social Services Committee. She was also a founding member of the Fleur-de-Lis Ambassadors program and is currently president-elect of the Louisiana State Bar Association.

Michael is president and chief executive officer of City of Hope, an independent biomedical research, treatment and education institution, located near Los Angeles. City of Hope is a world leader in the fight to conquer cancer, diabetes, HIV/AIDS and other life-threatening diseases. Before arriving at City of Hope, Michael was a senior vice president of research and development at Pharmacia Corporation. Following the events of September 11, 2001, he also simultaneously served as chief medical officer for biomedical preparedness at the Pharmaceutical Research and Manufacturers of America. He previously served as the U.S. Food and Drug Administration (FDA) Deputy Commissioner and was then tapped by the Clinton administration to serve as acting commissioner of the FDA.

Michael received his bachelor of arts degree, magna cum laude, from Tulane University and a doctorate in medicine from the University of Texas. He completed postdoctoral training at Stanford University and the National Cancer Institute and is board certified in Internal Medicine and Medical Oncology.

Together Michael and Kim bring a wealth of knowledge, leadership, vision and dedication to our board. I look forward to their guidance and counsel as we continue to fulfill the promise of Tulane.

Have a great weekend,